Az inzulinadagoló pumpakezelés gyakorlata a bizonyítékok tükrében

Translated title of the contribution: Evidence based practice of insulin pump therapy

Z. Kerényi, Wudi Krisztina, G. Tamás

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The insulin pump treatment in the form of a continuous subcutaneous insulin infusion (CSII) - known for thirty years and nowadays proved to be safe and effective - is one of the potential and widely used methods of intensified therapy in type 1 diabetic patients. Evidences and meta-analyses confirm the favourable effect of pump treatment compared to multiple daily insulin injection regimens with a 0,2-0,7% decrease in the HbAlc value. The fall of the frequency of severe hypoglycaemias during the use of CSII reported earlier cannot be unequivocally proven today in the era of the modern conservative insulin regimens. The use of CSII might ameliorate quality of life, it might be a cost-effective form of therapy using properly and in the right persons. Its application has to be considered in well-educated type 1 diabetic patients with a higher than desirable HbAlc value despite aiming at normoglycaemia. The real-time continuous glucose monitoring augmented pump therapy might help in further improvement of glycaemic control in appropriately chosen patients. This technological development with "closing the loop" creates the possibility of an automatic glucoseregulation, the long-standing dream "artificial pancreas".

Original languageHungarian
Pages (from-to)137-144
Number of pages8
JournalOrvoskepzes
Volume85
Issue number2
Publication statusPublished - 2010

Fingerprint

Evidence-Based Practice
Insulin
Subcutaneous Infusions
Therapeutics
Artificial Pancreas
Meta-Analysis
Quality of Life
Costs and Cost Analysis
Glucose
Injections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az inzulinadagoló pumpakezelés gyakorlata a bizonyítékok tükrében. / Kerényi, Z.; Krisztina, Wudi; Tamás, G.

In: Orvoskepzes, Vol. 85, No. 2, 2010, p. 137-144.

Research output: Contribution to journalArticle

@article{e2021e1a2a3a4e42aa615d06d65887c5,
title = "Az inzulinadagol{\'o} pumpakezel{\'e}s gyakorlata a bizony{\'i}t{\'e}kok t{\"u}kr{\'e}ben",
abstract = "The insulin pump treatment in the form of a continuous subcutaneous insulin infusion (CSII) - known for thirty years and nowadays proved to be safe and effective - is one of the potential and widely used methods of intensified therapy in type 1 diabetic patients. Evidences and meta-analyses confirm the favourable effect of pump treatment compared to multiple daily insulin injection regimens with a 0,2-0,7{\%} decrease in the HbAlc value. The fall of the frequency of severe hypoglycaemias during the use of CSII reported earlier cannot be unequivocally proven today in the era of the modern conservative insulin regimens. The use of CSII might ameliorate quality of life, it might be a cost-effective form of therapy using properly and in the right persons. Its application has to be considered in well-educated type 1 diabetic patients with a higher than desirable HbAlc value despite aiming at normoglycaemia. The real-time continuous glucose monitoring augmented pump therapy might help in further improvement of glycaemic control in appropriately chosen patients. This technological development with {"}closing the loop{"} creates the possibility of an automatic glucoseregulation, the long-standing dream {"}artificial pancreas{"}.",
keywords = "Continuous subcutaneous insulin infusion, Evidence based, Insulin pump, Insulin treatment, Meta-analysis",
author = "Z. Ker{\'e}nyi and Wudi Krisztina and G. Tam{\'a}s",
year = "2010",
language = "Hungarian",
volume = "85",
pages = "137--144",
journal = "Orvoskepzes",
issn = "0030-6037",
publisher = "Semmelweis Kiado",
number = "2",

}

TY - JOUR

T1 - Az inzulinadagoló pumpakezelés gyakorlata a bizonyítékok tükrében

AU - Kerényi, Z.

AU - Krisztina, Wudi

AU - Tamás, G.

PY - 2010

Y1 - 2010

N2 - The insulin pump treatment in the form of a continuous subcutaneous insulin infusion (CSII) - known for thirty years and nowadays proved to be safe and effective - is one of the potential and widely used methods of intensified therapy in type 1 diabetic patients. Evidences and meta-analyses confirm the favourable effect of pump treatment compared to multiple daily insulin injection regimens with a 0,2-0,7% decrease in the HbAlc value. The fall of the frequency of severe hypoglycaemias during the use of CSII reported earlier cannot be unequivocally proven today in the era of the modern conservative insulin regimens. The use of CSII might ameliorate quality of life, it might be a cost-effective form of therapy using properly and in the right persons. Its application has to be considered in well-educated type 1 diabetic patients with a higher than desirable HbAlc value despite aiming at normoglycaemia. The real-time continuous glucose monitoring augmented pump therapy might help in further improvement of glycaemic control in appropriately chosen patients. This technological development with "closing the loop" creates the possibility of an automatic glucoseregulation, the long-standing dream "artificial pancreas".

AB - The insulin pump treatment in the form of a continuous subcutaneous insulin infusion (CSII) - known for thirty years and nowadays proved to be safe and effective - is one of the potential and widely used methods of intensified therapy in type 1 diabetic patients. Evidences and meta-analyses confirm the favourable effect of pump treatment compared to multiple daily insulin injection regimens with a 0,2-0,7% decrease in the HbAlc value. The fall of the frequency of severe hypoglycaemias during the use of CSII reported earlier cannot be unequivocally proven today in the era of the modern conservative insulin regimens. The use of CSII might ameliorate quality of life, it might be a cost-effective form of therapy using properly and in the right persons. Its application has to be considered in well-educated type 1 diabetic patients with a higher than desirable HbAlc value despite aiming at normoglycaemia. The real-time continuous glucose monitoring augmented pump therapy might help in further improvement of glycaemic control in appropriately chosen patients. This technological development with "closing the loop" creates the possibility of an automatic glucoseregulation, the long-standing dream "artificial pancreas".

KW - Continuous subcutaneous insulin infusion

KW - Evidence based

KW - Insulin pump

KW - Insulin treatment

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=82555205076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82555205076&partnerID=8YFLogxK

M3 - Article

VL - 85

SP - 137

EP - 144

JO - Orvoskepzes

JF - Orvoskepzes

SN - 0030-6037

IS - 2

ER -